5/ Get older conservatives to reach out to younger conservatives.
Older conservatives are more likely to remember kids paralyzed from polio and may be more likely to have had or know someone who's had a serious bout of COVID than younger conservatives.
2/ @NIH@NIAIDNews
Phase I/II clinical trial of boosting 12+ weeks
after 2 Moderna, 2 Pfizer, or 1 J&J
- To assess safety & reactogenicity
- To assess the breadth of humoral immune responses clinicaltrials.gov/ct2/show/NCT04…
3/ They're studying all possible combinations:
1 J&J➡️1 Moderna
1 J&J➡️1 J&J
1 J&J➡️1 Pfizer
2 Moderna➡️1 Moderna
2 Moderna➡️1 J&J
2 Moderna➡️1 Pfizer
2 Pfizer➡️1 Moderna
2 Pfizer➡️1 J&J
2 Pfizer➡️1 Pfizer
With follow-up 14d, 28d, 3m, 6m, 12m after the booster dose.
1/ Merck/Ridgeback, Pfizer, & Roche/Atea all have oral antiviral pills for the treatment of COVID in phase II/III clinical trials.
We anticipate results in the next couple of months with submission to the @US_FDA to follow soon thereafter.
But will these be game-changing?
2/ Remdesivir & monoclonal antibodies, both therapeutics for COVID, haven't been game-changing.
It's BEST to prevent COVID with VACCINATION.
But it's good to have COVID therapeutics as a backup measure, especially for older & more vulnerable or immunocompromised people.
3/ COVID drugs work by blocking the machinery that allows the virus to replicate. This reduces the viral load and the duration of infection. But if the damage has already been done, COVID drugs won't reverse that.
1/ @KFF September vaccine monitor survey:
- FEAR is a powerful motivator. Delta surge has been the PRIMARY MOTIVATOR for recently vaccinated.
- FDA approval & mandates have also played a role.
2/ - Biggest increases in vaccine uptake among Hispanic adults & young adults 18-29.
- Similar % of adults vaccinated by race/ethnicity:
- White 71%
- Black 70%
- Hispanic 73%
- Gaps remain by partisanship, education level, age, health insurance status
3/ “When a theoretical threat becomes a clear and present danger, people are more likely to act to protect themselves and their loved ones,” said @DrewAltman, the @KFF's chief executive.
2/ Are we giving boosters to people in high-risk occupations:
- To protect them because they're at high risk for severe disease?
OR
- For the safety of the workplace & to keep them on the job?
3/ There isn't good data to support giving boosters to people in high-risk occupations to protect THEM from severe disease.